SCHEMBL1675378

SCHEMBL1675378

c1nc(N2CCOCC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 14/20 0.77
CYP1A2 P05177 13/20 0.77
CLK4 Q9HAZ1 12/20 0.77
LMNA P02545 10/20 0.77
CYP2C19 P33261 10/20 0.77
MAPK1 P28482 10/20 0.77
CYP2D6 P10635 9/20 0.77
HIF1A Q16665 9/20 0.77
ALDH1A1 P00352 8/20 0.77
USP2 O75604 4/20 0.77
MEN1 O00255 3/20 0.77
KMT2A Q03164 3/20 0.77
HSD17B10 Q99714 5/20 0.62
KDM4E B2RXH2 2/20 0.62
MAPT P10636 2/20 0.62
HPGD P15428 1/20 0.62
TSHR P16473 7/20 0.60
TP53 P04637 2/20 0.56
ALOX15 P16050 1/20 0.56
PTK2 Q05397 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675322 0.89 CLK4 (0.78) CYP3A4CYP1A2CLK4LMNACYP2C19
SCHEMBL1675259 0.87 CYP1A2 (1.00) CYP3A4CYP1A2CLK4LMNACYP2C19
SCHEMBL1675346 0.82 CLK4 (0.68) CYP3A4CYP1A2CLK4LMNACYP2C19
SCHEMBL4357245 0.81 CLK4 (0.70) CYP3A4CYP1A2CLK4LMNACYP2C19
SCHEMBL4351394 0.81 CYP3A4 (0.70) CYP3A4CYP1A2CLK4LMNACYP2C19
SCHEMBL4121396 0.78 CLK4 (0.73) CYP3A4CYP1A2CLK4LMNACYP2C19
SCHEMBL4355316 0.77 GAK (0.83) CYP3A4CYP1A2CLK4LMNACYP2C19
SCHEMBL3111815 0.76 CYP3A4 (0.63) CYP3A4CYP1A2CLK4LMNACYP2C19
SCHEMBL12927745 0.75 CLK4 (0.61) CYP3A4CYP1A2CLK4LMNACYP2C19
SCHEMBL731931 0.75 CYP3A4 (0.65) CYP3A4CYP1A2CLK4LMNACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed